Skip to main content
. 2021 Jan 4;15(8):2106–2119. doi: 10.1002/1878-0261.12888

Table 1.

Doxorubicin IC50 obtained through nonlinear regressions.

A2780 A2780CP Ishikawa ECC‐1
Monotherapy (Doxorubicin) (nm) 52.15 67.85 55.75 95.53
Combined therapy (AZD5363 + Doxorubicin) (nm) 6.07 29.09 26.03 22.3